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Background: Hemorrhagic shock results in systemic activation of the immune system and leads to
ischemia-reperfusion injury. Lymphocytes have been identified as critical mediators of the early innate immune
response to ischemia-reperfusion injury, and immunomodulation of lymphocytes may prevent secondary
immunologic injury in surgical and trauma patients.
Methods: Yorkshire swine were anesthetized and underwent a grade III liver injury with uncontrolled hemorrhage to
induce hemorrhagic shock. Experimental groups were treated with a lymphocyte depletional agent, porcine polyclonal
anti-thymocyte globulin (PATG) (n= 8) and compared to a vehicle control group (n= 9). Animals were observed over a
3 day survival period. Circulating lymphocytes were examined with FACS analysis for CD3/CD4/CD8, and central
lymphocytes with mesenteric lymph node and spleen staining for CD3. Circulating and lung tissue16 infiltrating
neutrophils were measured. Circulating CD3 lymphocytes in the blood and in central lymphoid organs (spleen/lymph
node) were stained and evaluated using FACS analysis. Immune-related gene expression from liver tissue was
quantified using RT-PCR.
Results: The overall survival was 22% (2/9) in the control and 75% (6/8) in the PATG groups, p = 0.09; during the
reperfusion period (following hemorrhage) survival was 25% (2/8) in the control and 100% (6/6) in the PATG groups,
p = 0.008. Mean blood loss and hemodynamic profiles were not significantly different between the experimental and
control groups. Circulating CD3+CD4+ lymphocytes were significantly depleted in the PATG group compared to
control. Lymphocyte depletion in the setting of hemorrhagic shock also significantly decreased circulating and lung
tissue infiltrating neutrophils, and decreased expression of liver ischemia gene expression.
Conclusions: Lymphocyte manipulation with a depletional (PATG) strategy improves reperfusion survival in
experimental hemorrhagic shock using a porcine liver injury model. This proof of principle study paves the way for
further development of immunomodulation approaches to ameliorate secondary immune injury following
hemorrhagic shock.
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The immune system is teleologically designed to respond
only to local injury and is necessary for hemostasis, pro-
tection against microorganism invasion, and initiation of
tissue repair. Severe trauma and hemorrhagic shock in-
duce a systemic inflammatory response that results in* Correspondence: eric.elster1@med.navy.mil
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distribution, and reproduction in any mediuminappropriate immune activation and secondary injury
to the host [1]. Systemic inflammatory intensification
following injury manifests clinically as the systemic in-
flammatory response syndrome, acute respiratory distress
syndrome, and ultimately multi-organ dysfunction syn-
drome manifests clinically from SIRS, to ARDS, and ul-
timately to MOD [2]. Modulation of the immunologic
response to injury is a major therapeutic goal to reduce
associated morbidity and mortality and improve trauma
outcomes.ntral Ltd. This is an Open Access article distributed under the terms of the
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chemia reperfusion injury has focused on monocyte and
neutrophil adhesion blockade. However, despite promising
preclinical data, results of phase 2 and 3 trials of neutro-
phil anti-adhesion therapy in ischemia-reperfusion injury
(IRI) disorders have been disappointing [3]. In two clini-
cal trials testing humanized CD18 monoclonal antibo-
dies in the setting of traumatic injury, mortality and other
primary end points were not significantly affected [4,5].
These failures are likely the result of the redundancy
of adhesion pathways, but also suggest that the neu-
trophil is not central in the innate immune response to
IRI.
Lymphocytes have recently been identified as critical
mediators of the early innate immune response to injury.
There is emerging evidence that T lymphocytes are ra-
pidly activated in an alloantigen-independent manner in
the setting of IRI [6,7]. Hypoxia is thought to be suffi-
cient for lymphocyte activation, as CD4+ lymphocytes
have been shown to increase adhesion to endothelial mo-
nolayers following anoxia modulation [8,9]. Furthermore,
lymphocytes have been shown to rapidly accumulate in
target organs following ischemia and may represent very
early cellular mediators of reperfusion injury [7]. The role
of T lymphocytes as critical cellular mediators of the in-
nate immune response to IRI has been corroborated in
multiple IRI models [10-14]. In a renal IRI model, geneti-
cally engineered mice deficient in both CD4+ and CD8+
lymphocytes had substantially less kidney dysfunction
after renal ischemia than did wild-type control mice
[15]. Mice deficient in CD4+ and CD8+ lymphocytes also
demonstrated less tissue neutrophil infiltration, suggesting
that lymphocytes orchestrate cell-mediated innate respon-
ses to ischemia. Altogether, these studies demonstrate a
novel, innate function of lymphocytes in the setting of is-
chemic injury. Thereby, immunomodulation of lympho-
cytes may offer a novel approach to attenuate detrimental
immune responses to severe traumatic injury.
Antithymocyte globulin (ATG) is a potent lymphocyte
depleting agent that is used clinically in induction and
antirejection therapy for solid organ transplantation,
treatment of graft versus host disease, and selected auto-
immune diseases [16,17]. The primary mechanism of im-
munosuppression involves massive peripheral and central
lymphocyte depletion primarily by complement and Fas/
Fas-L mediated apoptosis pathways [18-20]. In addition,
ATG results in antibody inhibition of nondepleted T lym-
phocytes and functional alteration of several membrane
receptors (TCR/CD3) and coreceptors (CD2, CD4, and
CD8) [18,21]. Given the innate role of the lymphocyte in
IRI, ATG may effectively modulate the post-traumatic in-
flammatory response.
In this study, we investigated a lymphocyte depletion
strategy in a large animal liver injury shock model. Wedeveloped a porcine specific ATG in order to determine
if lymphocyte depletion improves survival following ex-
perimental hemorrhagic shock.
Methods
The experiments reported herein were conducted accor-
ding to the principles set forth in the “Guide for the Care
and Use of Laboratory Animals,” Institute of Laboratory
Animals Resources, National Research Council, National
Academy Press, 2011. The study was approved by the
National Medical Research Center Institutional Animal
Care and Use Committee (IACUC) and all procedu-
res were performed in animal facilities approved by
the Association for Assessment and Accreditation for
Laboratory Animal Care International (AAALAC).
Development of porcine anti-thymocyte globulin (PATG)
Porcine thymuses were obtained aseptically from normal
unmanipulated control pigs, and single-cell suspensions
were prepared by gentle pressing thorough a nylon filter
mesh (Tetko, Inc, Elmsford, NY USA) into cold RPMI
1640 medium (GIBCO, Grand Island, NY USA). Thymo-
cytes were isolated on density gradients using Ficoll-Paque
(Pharmacia Biotech, Uppsala, Sweden) to remove reds cells
and granulocytes, washed three times and then resus-
pended in Dulbecco phosphate buffered saline (D-PBS;
GIBCO). All cell preparations had a purity of >95% lym-
phocytes (data not shown).
To produce polyclonal antibody against porcine thy-
mocytes, 125 adult female New Zealand White rabbits
(Covance, Denver, PA USA) were immunized subcuta-
neously with 5 × 106 purified porcine thymocytes in com-
plete Freund’s adjuvant (Sigma, St. Louis, MO, USA).
Subsequent intravenous booster immunizations of 5 × 106
thymocytes were given on days 14, 28 and 42. The rabbits
were terminally bled, by cardiac puncture, 7 days after the
final immunization. The collected blood was pooled and
sera isolated by centrifugation. The Ig fraction was pu-
rified using Protein G Sepharose-4 Fast Flow columns
(Pharmacia), sterile filtered (0.2 μm) and stored at 4°C be-
fore use. All PATG used in these studies was obtained
from a single batch and was tested to be endotoxin-low
(<0.05 IU/mg) by QCL-1000 Chromogenic LAL (Cambrex
BioWhitaker Biosciences, Walkersville, MD USA).
The titer of antiserum was tested by FACS analysis
to measure antibody binding-coating of PATG to the
cell surface of purified porcine thymocytes and peripheral
blood leukocytes (gated lymphocyte, monocyte and gra-
nulocyte cell populations). Cells (1 × 106/100 μl) were
incubated at 4°C with PATG at concentrations ranging
from 0.01 μg/ml to 100 μg/ml, washed, and incubated
with FITC-labeled goat anti-rabbit antibody (Jackson
ImmunoResearch Laboratories, West Grove, PA USA).
Results were compared to with cells incubated with the
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exhibited stronger titer to thymocytes and peripheral
blood CD4+ T-cells (receptor sites saturated ≥ 0.5 μg/1
× 106 cells) than to peripheral blood granulocytes and
monocytes (100 to 300-fold greater; data not shown). We
performed a dose–response experiment and determined
that 4 PATG doses of 10 mg/kg 24 hours apart were ne-
cessary for >50% sustained lymphocyte depletion (data
not shown).
Animal preparation
Male and female 3–12 month Yorkshire (Sus scrofa
domestica) swine weighing 25-35 kg were acquired from
ABI Farms (Donsboro, PA). Feed was withheld 12 hours
before surgery. Prior to surgery, animals were sedated and
anesthesia induced with intramuscular ketamine hydro-
chloride (12–20 mg/kg) and xylazine (2.2 mg/kg) as well
as atropine sulfate (0.05 mg/kg) to decrease tracheal secre-
tions. Mask ventilation with Isoflurane (5.0%) was used
to facilitate endotracheal intubation. Pigs were venti-
lated (Ohmeda 7800 series ventilator, Datex, Madison,
WI) at 12–15 breaths/min and tidal volume 10 mL/kg.
Anesthesia was maintained with Isoflurane (1.5-2.5%) in
21-25% O2.
Following adequate anesthesia the right external and
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Figure 1 Experimental design. A) Liver injury was initiated at t = 0. Unco
abdomen was packed and temporarily closed (pre-hospital phase). The ani
liver was repaired and the abdomen definitively closed. The animal was th
as indicated. Necropsy was performed when the animal expired or at 72 h
hospital phases were considered the hemorrhage period, while the hospita
experimental group, 4 doses of PATG (10 mg/kg) were administered startin9Fr dual-lumen, tunneled Hickman catheter was placed
in the external jugular vein for drug infusion and blood
collection during the survival period. A 9Fr introducer
sheath was placed in the internal jugular vein and a 7.5Fr
pulmonary artery catheter (PAC; Edwards Life Sciences,
Irvine, CA) was inserted for continuous hemodynamic
monitoring. An 18 G Angiocath was placed in the carotid
artery and mean arterial pressure (MAP) was continuously
transduced. A midline laparotomy was performed to ex-
pose the liver and isolate the left lateral lobe. Urine was
collected via bladder catheterization. Rectal temperature
was monitored continuously. Normothermia (37°C) was
maintained with a warming device (Model 505, Bair
Hugger, Augustine Medical, Eden Prairie, MN).
Liver injury and resuscitation
All animal groups underwent a standardized liver injury
and resuscitation protocol (Figure 1A). A reproducible
liver injury was created by placing a ring clamp over the
left lower lobe, 50% in width and 3.5-5 mm from the
apex, adjusting for the relative size of the animal [22].
The clamp was closed and a 10 blade was used to lace-
rate the lobe from the top of the clamp through the
remaining width. The liver injury denoted the start of
the pre-hospital phase (Time 0). After 1 minute, the clamp
was removed and the remaining tissue excised, resultingHospital 
Care
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ntrolled hemorrhage occurred until 1 hour, at which time the
mal was observed until 2 hours when hospital care was initiated. The
en observed for a total of 72 hours. Blood transfusion was administered
ours following euthanasia. The uncontrolled hemorrhage and pre-
l care phase was considered the reperfusion period. B) In the PATG
g 96 hours prior to liver injury.
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jury. The hepatectomy specimen was weighed and divided
by animal weight (kg) and reported as hepatectomy weight
index (g/kg). Bleeding was spontaneous and removed
continually via suction and quantified by weight. Blood
loss weight (g) was used to calculate estimated blood
loss volume (%). At 15 minutes, animals were infused
250 mL normal saline (NS) over the next 60 minutes.
This time point represents the arrival of a first responder
(e.g. medic) who has limited carrying capacity. After 1
hour blood collection was discontinued and the abdo-
men packed then closed with towel clips.
After a total of 2 hours, the pre-hospital phase was
completed and hospital arrival was simulated. This time
point represents arrival of the patient to a hospital with
surgical capabilities. The abdomen was reopened, resi-
dual blood suctioned, sponges collected, and blood loss
quantified by weight. The liver injury was repaired with
suture and the abdomen definitively closed. Invasive lines
were removed and the carotid artery repaired. One unit
of allogeneic whole blood (10 mL/kg) (Thomas Morris,
Reisterstown, MD) was administered for hemoglobin <7 g/
dL, otherwise animals received additional NS at 10 mL/kg.
Anesthesia was stopped and the animals extubated.Experimental group
Animals in the PATG group were anesthetized and under-
went tunneled Hickman catheter placement 4 days prior
to liver injury. PATG (10 mg/kg) was diluted in 250 mL
NS and infused daily for 4 doses total (Figure 1B). Several
animals experienced hemodynamic instability during the
first infusion of PATG, likely secondary to cytokine release
phenomena. Subsequently, the protocol was modified and
one dose of Solumedrol (2 mg/kg) was administered prior
to only the first PATG infusion which abrogated this drug
effect.Post-surgical care
Pigs were allowed to eat a regular diet and drink water fol-
lowing surgery. Buprenorphine (0.05-0.1 mg/kg IM/IV)
was administered every 6–12 hours if the animals demon-
strated any sign of pain. If the pigs showed any sign of se-
vere disability (e.g. inability to ambulate, eat, drink), severe
infection, or uncontrolled pain, they were euthanized
(Euthasol, Virbac AH, Fort Worth, TX) and taken for nec-
ropsy. At the end of the survival period (72 hours post-
injury), surviving pigs were euthanized and taken for
necropsy. Samples of the heart, lung, liver, kidney, small
intestine, mesenteric lymph node, and spleen were taken.
A portion of each sample was submitted for histology.
Additional samples were placed in RNALater (Qiagen,
Valencia, CA) and flash frozen using liquid nitrogen with-
in 48 hours. These samples were stored at −80°C.Laboratory data
All functional laboratory assays were performed at 37°C,
consistent with recorded normothermic animal tempera-
tures (37.5 ±0.9°C). Blood samples were collected at 0, 15,
30, 60, 90, and 120 minutes during the hemorrhage period
and at 18, 24, 36, 48, and 72 hours during the sur-
vival period. Complete blood count with differentiation
was performed with a cell counter (NDvia120 Hematology
System, Siemens, Deerfield, IL).
Flow cytometry
Whole blood was fractionated using Histopaque 1077
(Sigma, St. Louis, MO) density gradient centrifugation.
Fluorescent immunostaining of the isolated mononuclear
cells was accomplished via a 30-minute incubation at 4°C
with fluorescein isothiocyanate (FITC)-labeled CD3 and
either phycoerythrin (PE)-labeled CD4 or CD8 mouse
anti-porcine antibodies (BD Pharmingen, San Jose, CA).
The cells were washed in FACS buffer (3% FBS, 1% so-
dium azide), fixed using 1.6% paraformaldehyde, and
quantified by flow cytometry (Beckman-Coulter, Hialeah,
FL). Appropriate mouse IgG isotype controls were used
(BD Pharmingen, San Jose, CA). Flow cytometry analysis
was performed with FACS Calibur (Becton Dickinson).
Statistical analysis of the FACS data was performed with
CellQuest (Becton Dickson).
Immunohistochemistry
Tissue slides were deparaffinized using xylene followed
by graded baths of ethanol. A DAKO Autostainer Plus
Universal Staining System (DAKO, Carpenteria, CA) was
used for automated immunohistochemical staining.
Immunohistochemical detection of CD3 was performed
on sections of formalin fixed, paraffin embedded blocks of
swine lymph node and spleen. Antigen retrieval was per-
formed using Trilogy (Cell Marque, Rocklin, CA) for
30 minutes. Rat, anti- human CD3, monoclonal antibody
(AbD Serotec, Raleigh, NC) was used at a dilution of 1:50
and incubated overnight at 4C. Biotinylated goat anti-rat
IgG specific polyclonal antibody (BD Biosciences, San
Jose, CA) was applied as a secondary antibody at a
1:100 dilution for 30 minutes at room temperature. The
chromogen applied was 3, 3’ Diaminobenzidine (DAKO,
Carpenteria, CA) for 10 minutes. The sections were coun-
terstained with Hematoxylin (DAKO, Carpenteria, CA).
External negative controls were processed identically as
CD3 but the primary antibody was substituted with nor-
mal rat serum. A tissue sample was considered positive if
reactive cells, lymphocytes, demonstrated reactivity. An
Automated Cellular Imaging System (ACIS) was used to
quantify the CD3 immunohistochemistry staining. By
using the ACIS system, CD3 immunohistochemical stai-
ning could be specifically quantitated by determining
how much brown (positive CD3 immunohistochemical
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blue (hematoxylin nuclear counterstain).
Immunohistochemical detection of MPO was per-
formed on sections of formalin fixed, paraffin embedded
blocks of swine lung. Antigen retrieval was performed
using Proteinase K (DAKO, Carpenteria CA) for 30
minutes. Polyclonal rabbit, anti- human MPO (DAKO,
Carpenteria CA) was used at a ready to use dilution and
incubated at room temperature for 30 minutes. Envision,
anti-rabbit (DAKO, Carpenteria CA) was applied as a
secondary antibody for 30 minutes at room temperature.
The chromogen applied was 3, 3’ Diaminobenzidine
(DAKO, Carpenteria, CA) for 10 minutes. The sections we-
re counterstained with Hematoxylin (DAKO, Carpenteria,
CA). External negative control was processed identically as
with MPO but the primary antibody was substituted with
normal rabbit serum. A tissue sample was considered posi-
tive if reactive cells, neutrophils, demonstrated reactivity in
conjunction with a segmented nucleus. Neutrophils were
noted mainly in circulation in small septal vessels and in
large vessels. Cells with appropriate nuclear morphology
and the presence of light to intensely reactive granules were
counted; 5 random 40x fields were assessed.RNA extraction and quantitative real-time polymerase
chain reaction
Total RNA was isolated from liver tissue taken at necrop-
sy using Qiagen RNeasy Mini Kit (Qiagen Inc. Valencia,
CA) according to manufacturer’s instructions. RNA purity
and quantity were assessed by measuring the A260, A280,
and A230on a Nanodrop Spectrophotometer (NanoDrop
Technologies Inc. Wilmington, DE). RNA quality was de-
termined from the 28S/18S rRNA ratio and RNA Integrity
Number (RIN) using an Agilent 2100 BioAnalyzer (Agilent
Technologies Inc. Santa Clara, CA). RIN values for all spe-
cimens in this study were ≥6.5. Reverse transcriptions were
performed using Roche 1st Strand Synthesis kits (Roche
Diagnostics Corporation, Indianapolis, IN) according to
the manufacturer’s protocol. Quantitative real-time poly-
merase chain reaction (QRT-PCR) was performed using
the 7900HT Fast Real-Time PCR System (Applied Biosys-
tems, Foster City, CA) to assess mRNA transcript expres-
sion of 21 immune-related genes. Taqman chemistry was
used. Primers for 18S rRNA target were used as an internal
control for each reaction. Primers and probes for the tar-
gets of interest were obtained from Applied Biosystems.
All samples were run in duplicate. Individual samples were
compared to averaged control tissue expression. Transcript
quantification was derived using the comparative threshold
cycle method [23] and reported as the median n-fold dif-
ference of the experimental sample to the control pool.
Satisfactory mRNA was available for PATG (n=6) was
compared to the control (n=5) group.Statistical analysis
Animals were randomly assigned to the control or ex-
perimental groups. Survival analysis between groups was
performed by Kaplan Meier survival plots with the log
rank test. Continuous data was compared with the Stu-
dent t-test or nonparametric tests as appropriate. Multiple
comparisons were performed with one-way ANOVA. A
one-way ANOVA with repeated measures design was used
for continuous time-dependent comparisons. Statistical
analysis was performed using SPSS (SPSS Inc., Chicago,
IL). A two-tailed p value < 0.05 was considered statistically
significant. All data is represented as means ± standard er-
ror (SEM) unless otherwise specified.
Results
Animal characteristics and hemodynamic profiles during
hemorrhage period
Mean animal weight and gender distribution were not sig-
nificantly different between the control (n = 9) and PATG
(n=8) groups (Table 1). The mean hepatectomy weight
index was similar between groups indicating that the liver
injury was well standardized. In addition, the majority of
animals in both groups required blood transfusion during
the hospital phase for hemoglobin value <7 g/dL.
Invasive hemodynamic monitoring during the hemor-
rhage period demonstrated shock physiology in all animal
groups (Figure 2). Cardiac output and mean arterial pres-
sure were significantly decreased and heart rate signi-
ficantly increased compared to baseline. The heart rate
increased markedly in the PATG group, possible due to
cytokine release phenomena.
Lymphocyte depletion significantly improved reperfusion
survival
Overall survival in the experimental group was improved
compared to control, although not statistically significant
by log rank test (Figure 3A). The control group survival
was 22% (2/9) and PATG was 75% (6/8) p = 0.09. Du-
ring the reperfusion period (following hemorrhage) sur-
vival was statistically improved in the experimental group
compared to control (Figure 3B). Control group survival
was 25% (2/8) and PATG was 100% (6/6) p = 0.008 during
reperfusion.
Peripheral and central lymphocyte response to
hemorrhagic shock
We examined the peripheral, or circulating, and central
lymphocyte response to hemorrhagic shock in the experi-
mental and control groups. Peripheral lymphocyte counts
were significantly decreased in the PATG group during
the hemorrhage period compared to control, p = 0.001,
indicating effective lymphocyte depletion (Figure 4). Du-
ring the reperfusion period, peripheral lymphocyte counts
Table 1 Animal characteristics
Variable Control (n=9) PATG (n=8) p-value
Mean animal weight [kg] 32.5 ± 1.7 28.51 ± 0.8 NS1
Animal gender - M:F 5:4 4:4 NS2
Mean hepatectomy weight index [g/kg] 0.31 ± 0.04 0.33 ± 0.03 NS1
Mean blood loss volume% 46.8 ± 3.4 47.4 ± 4.0 NS1
Transfusion requirement - no. (%) 7 (78) 5 (63) NS2
1 Student t-test; 2 chi-squared; NS: not significant.
Figure 2 Hemodynamic profiles during hemorrhage period for
experimental and control groups. A) Heart rate. B) Mean arterial
pressure. C) Cardiac output.
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control.
CD3+CD4+ and CD3+CD8+ lymphocyte counts were
quantified throughout hemorrhage and reperfusion peri-
ods (Figure 5A,B). During the hemorrhage period, both
CD3+CD4+ (p= 0.001) and CD3+CD8+ (p< 0.001) lym-
phocytes were significantly reduced, indicating sustained
depletion. During reperfusion, CD3+CD4+ (p < 0.001) lym-
phocytes remained significantly depleted, but CD3+CD8+
(p= 0.7) lymphocytes were not different from controls.
Central lymphocytes were evaluated with CD3 immuno-
histochemistry staining of mesenteric lymph nodes and
spleen tissue at time of necropsy (Figure 6A). The CD3
staining was quantified, and in the PATG group, central
T-cells were decreased compared to control but this did
not reach statistical significance. Interestingly, significant
central T-cell sequestration was evident in the control
group compared to normal, unmanipulated mesenteric
lymph node and spleen tissue (p < 0.05). This finding sug-
gests that some degree of lymphocyte sequestration is part
of the normal response to hemorrhagic shock.
Altogether, PATG appeared to primarily affect periphe-
ral lymphocytes, and in particular CD4+ T-cells, under the
experimental conditions.Peripheral and tissue neutrophil response to hemorrhagic
shock
In order to study the innate cellular response to hemor-
rhagic shock, we examined peripheral and tissue neutro-
phils in the experimental and control groups. Throughout
the hemorrhage period, there was some evidence of peri-
pheral neutrophil depletion in the PATG group, although
not statistically significant when compared to control
(Figure 7). During reperfusion, peripheral neutrophils were
markedly increased in the control group, particularly du-
ring the peak reperfusion injury period (t = 24 hours). This
peripheral neutrophil response was attenuated in the
PATG (p=0.04) group throughout the reperfusion period.
The tissue neutrophil response to hemorrhagic shock
was evaluated by examining lung tissue neutrophil infiltra-
tion, a major target organ of neutrophils following shock
[24,25]. There was histologic evidence of significant neu-
trophil infiltration in control lung tissue (Figure 8A). This


























































Figure 3 Kaplan-Meier survival curve for experimental groups
versus control with log-rank test for statistical comparison. A)
Overall survival. B) Reperfusion period survival. Dashed red line































































Figure 5 CD3+CD4+ and CD3+CD8+ lymphocyte counts were
quantified throughout hemorrhage and reperfusion A)
Quantification of CD3+CD4+ and B) CD3+CD8+ lymphocytes
throughout the experiment. One-way ANOVA with repeated
measures design was used for statistical comparison. Error bars
represent ± SEM.
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red to normal, unmanipulated lung (Figure 8B). As with
the peripheral neutrophils, lung tissue neutrophils were
significantly decreased in the PATG (p = 0.003) group
compared to control. Thus, both peripheral and tissue




























Figure 4 Peripheral lymphocyte counts during hemorrhage and
reperfusion periods. One-way ANOVA with repeated measures
design was used for statistical comparison. Error bars
represent ± SEM.suggesting that lymphocyte manipulation also disrupted
the innate neutrophil response to hemorrhagic shock.
Immune molecular profile in hemorrhagic shock
We analyzed 21 immune-related gene mRNA transcripts
from liver tissue, a major effector organ of the systemic
immune response to shock [11]. Multiple immune targets,
including IL-1α, IL-2, IL-6, C3, CD154, HSP70 and COX-2,
were significantly down-regulated in the PATG group re-
lative to the control group (Figure 9). An apoptosis gene,
BCL-2, was up-regulated in the PATG group. Thus, lym-
phocyte depletion appeared to reduce liver inflammation
following hemorrhagic shock.
Discussion
In this study we demonstrate that lymphocyte depletion
significantly improves reperfusion survival following expe-
rimental hemorrhagic shock in a clinically relevant
swine model. Lymphocyte disruption appears to attenu-
ate innate cellular and molecular activation following
hemorrhagic shock, evident by significantly decreased
circulating and lung tissue infiltrating neutrophils and
Figure 6 Central lymphocyte counts at time of necropsy. A) Representative immunohistochemistry images ofanti- CD3 stains for normal,
control, and PATG tissue. B) Quantification of CD3+ reactivity by automated cellular Imaging. * indicates p < 0.05 compared to normal,
unmanipulated tissue. Data is depicted as mean± SEM.
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genes. Lymphocytes mediate critical innate events fol-
lowing hemorrhage, and lymphocyte modulation may
ameliorate reperfusion injury.
The innate role of lymphocytes offers the potential for


























Figure 7 Peripheral neutrophil counts during hemorrhage and
reperfusion periods. One-way ANOVA with repeated measures
design was used for statistical comparison. Error bars
represent ± SEM.hemorrhagic shock. While ATG is primarily used clinically
to suppress adaptive lymphocyte responses, pre-clinical
studies have demonstrated the utility of ATG in abroga-
ting innate immune responses. In a non-human primate
model, polyclonal ATG conferred a protective effect on
reperfusion injury following limb ischemia [26]. In clinical
kidney and liver transplantation, ATG has been shown to
reduce graft dysfunction associated with IRI [27]. Specifi-
cally, ATG has been shown to reduce delayed graft func-
tion following transplantation, an event that is thought to
be related to IRI.
Here we corroborate these findings in demonstrating
that lymphocyte depletion prior to hemorrhage reduces
innate immune-mediated injury during reperfusion. We
developed a pig specific ATG by immunizing rabbits
with purified populations of porcine thymocytes, similar
to Thymoglobulin (Genzyme, Cambridge, MA) currently
used in human clinical application [28]. PATG resulted in
significant peripheral lymphocyte depletion, which was
sustained during experimental hemorrhage. Total lympho-
cyte counts were not significantly reduced during the
reperfusion period compared to control, however CD4+ T
Figure 8 Lung tissue neutrophil counts at time of necropsy. A) Representative histology pictures of normal, control and PATG tissue. B)
Quantification of MPO+ cell reactivity. * indicates p < 0.05 compared to normal, unmanipulated tissue. † indicates p < 0.05 compared to control










































































































Figure 9 Gene transcript expression in liver tissue of PATG relative to the control group. Median value of relative fold expression is
depicted on a logarithmic scale. >2 fold difference from control was considered statistically significant and is indicated by *.
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riment. Central, including mesenteric lymph node and
spleen, T lymphocytes were not significantly depleted in
PATG animals compared to control. This may be an effect
of hemorrhage on lymphocyte trafficking, reducing the ef-
fect of PATG mediated depletion. Depletion of primarily
circulating lymphocytes, and in particular CD4+ T lym-
phocytes, appeared to be responsible for reduced immune
injury following hemorrhagic shock.
The significant depletion of CD4+ T lymphocytes in
the PATG group suggests a critical role for the CD4+ T
lymphocytes in modulating innate immune responses to
hemorrhage. The specific characterization of CD4+ T lym-
phocytes in IRI has been demonstrated in several animal
studies. In an elegant experiment, Rabb and colleagues
demonstrated that knockout mice deficient in CD4+ T
lymphocytes, but not mice deficient in CD8+ T lympho-
cytes, were significantly protected in a renal IRI model
[10]. Adoptive transfer of wild-type CD4+ lymphocytes
into these knockout mice restored the injury phenotype,
directly demonstrating the importance of CD4+ lympho-
cytes in IRI. Thus, the pathogenic role of CD4+ T lympho-
cytes in IRI may account for the immune protection in
the PATG group following hemorrhage.
Neutrophils are the earliest cellular mediators of IRI
following hemorrhage [29-31]. In particular, neutrophils
have been shown to mediate acute lung injury following
hemorrhagic shock, contributing to acute respiratory dis-
tress syndrome, a significant etiology of morbidity and mor-
tality after trauma [24,25]. Recent mechanistic studies have
demonstrated that lymphocytes may coordinate innate
neutrophil action following ischemic injury. In an intestinal
IRI model, T lymphocytes were shown to orchestrate neu-
trophil trafficking [11]. In the current study, lymphocyte
depletion resulted in a significant decrease in circulating
and tissue infiltration of neutrophils. The reduction in lung
tissue neutrophil infiltration likely contributed to the im-
proved survival in the PATG treated animals. Innate lym-
phocyte and neutrophil function may be intimately linked,
and lymphocyte disruption in the setting of hemorrhage
appears to abrogate neutrophil mediated immune injury.
Following hemorrhagic shock and severe injury, the
liver is responsible for initiating and sustaining the a-
cute inflammatory response [7]. Inflammatory mediators
released by the liver, including cytokines and chemokines,
direct the innate cellular response to IRI. We studied this
liver inflammatory response following hemorrhagic shock
with relevant immune gene expression. Inflammatory me-
diator expression, including IL-1a, IL-2, IL-6, C3, CD154,
HSP70, and COX-2, was significantly reduced in the
PATG treated animals. While Kupffer cells and neu-
trophils are thought to be the cells responsible for ini-
tiating and propagating the injury response, there is
an emerging view that both circulating and residentT-cells also regulate liver IRI. Circulating CD4+ T lym-
phocytes have been shown to rapidly recruit to the
liver within 1 hour following IRI, and contribute to
the early inflammatory mediator release [7]. In addition,
in a mouse liver ischemia model, a marked preserva-
tion of liver function was found in T lymphocytes de-
ficient athymic (nu/nu) mice compared to wild type
mice [12]. In our study, depletion of T lymphocytes with
PATG appeared to attenuate the liver specific inflamma-
tory response, further validating the lymphocyte as a thera-
peutic target for immunomodulation following shock.
An important limitation in the interpretation of this
study is the multitude of antibody specificities in poly-
clonal ATG preparations [32]. In addition to lymphocyte
depletion, ATG also interferes with leukocyte-endothelium
interactions by binding to adhesion molecules and chemo-
kine receptors [33], and these effects may account for some
of the observed immune protection in the experimental
group. Furthermore, ATG has B lymphocyte depletional
effects [34], while we focused primarily on the contribution
of only T-cell. B-cells have been shown to prevent IRI in
multiple models and may play an important role in the
post-injury immune response [35,36]. In addition, a rela-
tively high dose of PATG was required for >50 percent
lymphocyte depletion. High ATG doses can result in
hemolytic anemia, neutropenia, and thrombocytopenia
[18]. A non-statistically significant reduction in neutrophils
was observed in the experimental group, which may none-
theless confound the study results.
The current experiment is a proof of principle study, as
PATG was administered to animals prior to hemorrhage,
rather than after injury. We are currently investigating the
role of PATG administration following hemorrhage, how-
ever preliminary results suggest that the aforementioned
cytokine release phenomena results in prohibitive hemo-
dynamic changes in the setting of ongoing hemorrhage.
Regardless, there is a large array of pharmacologic stra-
tegies currently available that target lymphocyte function,
primarily for clinical use in the setting of transplan-
tation and autoimmune diseases. Humanized monoclo-
nal antibodies, such as anti-CD52 monoclonal antibody
(alemtuzumab), result in less cytokine release, and may be
clinically applicable following significant hemorrhage or in-
jury [37]. Importantly, the identification of lymphocytes as
important components of the innate immune system may
lead to harnessing advancements in lymphocyte biology for
novel hemorrhagic shock therapies. We are currently ex-
ploring these potential therapeutic pathways and have re-
cently demonstrated the efficacy of FTY720, a lymphocyte
sequestration agent, in our hemorrhagic shock model [38].
Conclusion
In conclusion, we demonstrate that lymphocyte deple-
tion significantly improves reperfusion survival in a large
Hawksworth et al. Journal of Inflammation 2012, 9:34 Page 11 of 12
http://www.journal-inflammation.com/content/9/1/34animal hemorrhagic shock model. PATG resulted in de-
pletion of primarily circulating T lymphocytes, and T
lymphocyte disruption appeared to attenuate innate cellu-
lar and molecular activation following hemorrhagic shock.
This proof of principle study paves the way for further de-
velopment of immunomodulation approaches to amelior-
ate reperfusion injury in trauma and surgical patients.Competing interests
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